Swipe the table sideways for more columns.

TrialConditionsStatusPhaseUpdatedMore infoNCT ID
A Phase 1 Dose-escalation Trial of KST-6051 in Participants With Advanced Solid Tumors With Kirsten Rat Sarcoma Viral Oncogene Homolog (KRAS) MutationBiliary Tract Neoplasms, Digestive System Diseases, Digestive System Neoplasms, Female Urogenital Diseases, Female Urogenital Diseases and Pregnancy Complications, Genital Diseases, Neoplasm Metastasis, Neoplasms by Histologic Type, Neoplasms by Site, Neoplastic Processes, Pathologic Processes, Pathological Conditions, Signs and Symptoms, Thoracic Neoplasms, Urogenital Diseases, Urogenital Neoplasms, adenocarcinoma, biliary tract disorder, carcinoma, cholangiocarcinoma, colonic disorder, colonic neoplasm, colorectal neoplasm, digestive system disorder, digestive system neoplasm, endocrine system disorder, endometrium neoplasm, epithelial neoplasm, female reproductive system disorder, female reproductive system neoplasm, intestinal disorder, lung disorder, lung neoplasm, malignant endocrine neoplasm, neoplasm, pancreas disorder, pancreatic neoplasm, rectal disorder, rectal neoplasm, respiratory system disorder, respiratory tract neoplasm, uterine disorderRecruitingPhase 12026-06-29NCT07458347

1 results · Page 1 of 1

Swipe the table sideways for more columns.

OrganizationsLinked trials
Kestrel Therapeutics, Inc.1

9 results · Page 1 of 1

Swipe the table sideways for more columns.

Research sitesCityCountryLinked trials
Cedars-Sinai Medical CenterLos AngelesUnited States392
Florida Cancer SpecialistsSarasotaUnited States47
Huntsman Cancer Institute, University of UtahSalt Lake CityUnited States45
Mass General Brigham Cancer Institute at Massachusetts General HospitalBostonUnited States2
Moffitt Cancer CenterTampaUnited States523
NEXT OncologySan AntonioUnited States70
NEXT VirginiaFairfaxUnited States83
Sidney Kimmel Cancer CenterPhiladelphiaUnited States4
The University of Texas MD Anderson Cancer CenterHoustonUnited States207